Skip to main content
. Author manuscript; available in PMC: 2022 Feb 1.
Published in final edited form as: Eur J Nucl Med Mol Imaging. 2020 Aug 8;48(2):383–394. doi: 10.1007/s00259-020-04978-6

Fig. 8.

Fig. 8

Whole-body biodistribution of [89Zr]ZrDFO-Amivantamab from 6 h to 7 days p.i. (n = 3 per group)